Healthcare stocks were mixed in afternoon trading, with the
S&P/TSX Healthcare index up 1.2%.
Merus Labs (MSL.TO): -8.8%
IMRIS (IM.TO): -2.0%
Valeant Pharmaceuticals (VRX.TO): +1.1%
Concordia Healthcare (CXR.TO): -5.4%
Novadaq Technologies (NDQ.TO): -5.9%
In company news, Merus Labs late Tuesday reported a much
narrower net loss for Q3 ended June 30, primarily due to higher
revenues. The pharmaceutical company said net loss was $171,666
versus a net loss of $1 million in the same period last year. The
decrease in loss was driven by the increase in revenues to $7.2
million from $6.6 million despite a drop in Vancocin sales to
$753,704 from last year's $1.6 million. Analyst estimates weren't
available for comparison.
Meanwhile, IMRIS has been granted three patents in Japan related
to key technology currently integrated into its intraoperative MRI
(iMRI) solution within the VISIUS Surgical Theatre. The covered
technology is utilized in VISIUS Surgical Theatres which are hybrid
operating room suites with iMRI where a diagnostic quality scanner
moves to the patient using ceiling-mounted rails.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.